Maternal exposure to methotrexate and birth defects: A population-based study

A Population Pharmacokinetic Model for Low-Dose Methotrexate and its Polyglutamated Metabolites in Red Blood Cells

(2013) Julia Korell et al.   CLINICAL PHARMACOKINETICS

Teratogen update: Methotrexate

(2012) Sara C. Hyoun et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Medical management of ectopic pregnancy: a 10-year case series

(2012) Alison Richardson   Human Fertility

Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy

(2011) Sarah H. Poggi et al.   FERTILITY AND STERILITY

Congenital Cardiac Defects: A Possible Association of Aminopterin Syndrome and In Utero Methotrexate Exposure?

(2011) Kurt D. Piggott et al.   PEDIATRIC CARDIOLOGY

Control Selection and Participation in an Ongoing, Population-based, Case-Control Study of Birth Defects

(2009) Mary E. Cogswell et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis

(2008) Judith M. Dalrymple et al.   ARTHRITIS AND RHEUMATISM